Nov 4, 2025 8:00 am EST Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
Oct 29, 2025 8:00 am EDT Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
Oct 23, 2025 8:00 am EDT Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
Oct 9, 2025 4:05 pm EDT Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 8, 2025 7:00 am EDT Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 7, 2025 8:00 am EDT Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
Oct 1, 2025 8:00 am EDT Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
Sep 25, 2025 8:00 am EDT Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Sep 24, 2025 8:00 am EDT Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
